- Adding to the confusion in more than just the name
-
George J
- KMID: 2546382
- Clin Mol Hepatol.
- 2023 Oct;29(4):973-976.
- doi: 10.3350/cmh.2023.0367
-
- CITED
-
- Close
- SHARE
-
- Close
- Injury Mechanisms of Hip Fractures in India
-
George J, Sharma V, Farooque K, Mittal S, Trikha V, Malhotra R
- KMID: 2525931
- Hip Pelvis.
- 2021 Jun;33(2):62-70.
- doi: 10.5371/hp.2021.33.2.62
Purpose: Hip fractures are a major cause of morbidity and mortality in the elderly; however, the current literature on the injury patterns of hip fractures in India is lacking. Understanding... -
- CITED
-
- Close
- SHARE
-
- Close
- MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
-
Kawaguchi T, Tsutsumi T, Nakano D, Eslam M, George J, Torimura T
- KMID: 2528243
- Clin Mol Hepatol.
- 2022 Apr;28(2):150-163.
- doi: 10.3350/cmh.2021.0310
Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in this region have distinctive characteristics. First, fatty liver is frequently observed in lean/normal-weight... -
- CITED
-
- Close
- SHARE
-
- Close
- MAFLD: How is it different from NAFLD?
-
Gofton C, Upendran Y, Zheng MH, George J
- KMID: 2539787
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S17-S31.
- doi: 10.3350/cmh.2022.0367
“Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation. The name change from nonalcoholic fatty liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
-
Baatarkhuu O, Lee HW, George J, Munkh-Orshikh D, Enkhtuvshin B, Ariunaa S, Eslam M, Ahn SH, Han KH, Kim DY
- KMID: 2413118
- Clin Mol Hepatol.
- 2017 Jun;23(2):147-153.
- doi: 10.3350/cmh.2016.0055
BACKGROUND/AIMS: Mongolia has one of the highest hepatitis A, C, B and D infection incidences worldwide. We sought to investigate changes in the proportion of acute viral hepatitis types in... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
-
Crane H, Eslick GD, Gofton C, Shaikh A, Cholankeril G, Cheah M, Zhong JH, Svegliati-Baroni G, Vitale A, Kim BK, Ahn SH, Kim MN, Strasser SI, George J
- KMID: 2557394
- Clin Mol Hepatol.
- 2024 Jul;30(3):436-448.
- doi: 10.3350/cmh.2024.0109
Background/Aims: The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis... -
- CITED
-
- Close
- SHARE
-
- Close
